Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets. Additionally, the Company has legacy programs in allergy and viral infections, and inner ear disorders, which it intends to partner as it plans to focus exclusively on the exciting opportunities in RNA.
Primary IR Contacts
U.S Tel: 800-460-0183
Data Provided by Refinitiv. Minimum 15 minutes delayed.